Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Better days ahead

MLG Oz
3:27pm
February 21, 2025
Top-line growth was strong (+20 YoY) but growth at EBITDA was limited (+3%), and higher D&A meant NPAT was well down on the pcp (-43%), in part due to the low base effect. We increase our revenue forecasts in FY25-26 (+9-10%) but leave our EBITDA forecasts unchanged. Our FY25 EBITDA forecast of $64m leaves MLG well and truly in the ‘2H club’, with $35m required in 2H (+19% HoH). That said, we are relatively comfortable that this is achievable given civil and crushing work has resumed which should support margins in 2H and likely into 1H26. Additionally, with gold miners finally producing strong margins and free cash flow as gold price benefits outweighing rising costs, we are hopeful that MLG can receive more favourable terms for new and renewed contracts.

A great glide path

Superloop
3:27pm
February 21, 2025
SLCs 1H25 result was slightly better than expected and FY25 guidance was reiterated. We think there is still more upside to come. Own branded consumer/ NBN continues to fly with record net adds while wholesale did well and is setup for a stellar 2H with Origin locked, loaded and growing fast. Business was the only weak spot but, this was well flagged due to industry challenges and SLC continues to outperform in a tough market, broadly holding business steady with volume growth. Overall, there continues to be a lot to like about the next twelve months and we reiterated our Add rating and lift our Target Price to A$2.60 (from A$2.40).

Booking record revenues in 1H25

HMC Capital
3:27pm
February 21, 2025
HMC’s HY25 result was a beat vs consensus as the company benefited from increased transaction fees ($72.8m vs $5.6m in pcp) and HMC Capital Partners (HMC-CP) investment uplift ($112.2m vs $22.1m in pcp), offset against a $24.2m HMC-CP performance fee provision. This saw revenue and EPS up significantly on the pcp and above consensus expectations. The 80 cps of annualised YTD net profit before tax (NPBT) exceeded the Nov-24 run-rate of 70 cps. The sterling performance through 1H25 leaves HMC well placed for FY25. The question then becomes what is the appropriate multiple for performance fees and transactions fees vs the recurring management fees – we would argue that recurring base management deserves the highest multiple. It is on this basis we retain our Hold recommendation, with our target price increased to $10.50/sh (previously $8.20/sh).

It doesn’t grow on trees

Fortescue
3:27pm
February 21, 2025
FMG posted a weak 1H25 compounded by a rise in gearing. FY25 energy capital expenditure guidance was lowered by -20% as FMG looks to reduce spend on its Green Energy Projects. Net debt increased +257% yoy following a significant decline in cash receipts and increased capital expenditure. We maintain a HOLD rating with a A$18.80ps target price (was A$18.90ps).

1H mixed; where to from here?

Healius
3:27pm
February 21, 2025
1H results were mixed, as underlying profit was in line on better than anticipated revenue growth, but a jump in finance costs saw net loss ahead of expectations. Pathology continues to be negatively impacted by inflationary pressures and Agilex went backwards on US election uncertainty, while soon to be sold Lumus Imaging was the standout, showing above market growth. While we note some operating improvements and greater emphasis on specialists in Pathology, how this translates into better profitability, while simultaneously reducing supporting costs, remains unclear, which makes forecasting challenging. Hopefully, we will gain greater insights at the Mar-25 investor day. We adjust FY25-27 estimates, with our target price decreasing to A$1.35. Hold.

Setting up for a 2H rebound

Mitchell Services
3:27pm
February 21, 2025
MSV’s 1H result held few surprises and the paused dividend was as expected. Guidance remains for an improved 2H versus the 1H, tempered by an eye on recent QLD rain. We think our unchanged operating forecasts remain conservative. FY25 shapes as a trough year for earnings, reflecting some market softening and MSV’s pivot into higher margin segments. However FY26 looks strongly set-up for higher earnings, cash conversion/ release and higher dividend returns. MSV remains far too cheap on all value measures and suits patient investors.

Capital strength vs persistent core hurdles

Magellan Financial Group
3:27pm
February 21, 2025
MFG reported adjusted NPAT of A$84.1m, down 10% on the pcp. The headline result was ahead of expectations, however earnings composition was weaker. Management fee margin fell meaningfully in the half (63bps from 70bps), with mgmt fee revenue down 4.7% HOH. Whilst the compression was largely FUM mix, overall fee pressure (rebates) and legacy pricing in retail vehicles remains an issue. Surplus capital of ~A$407m (>A$2.25/share) will be retained to support strategic initiatives. Further associate acquisitions are likely medium term. MFG’s near-term risk is outflows in the Infrastructure business (PM departure); and medium-term fee pressure (particularly ‘legacy’ retail pricing to work through). Whilst there is arguably value, we believe these fundamental risks need to dissipate before taking a more positive view.

Capital raise to fund data centre developments

Goodman Group
3:27pm
February 21, 2025
GMG has announced it will raise additional equity to fund the first stage of its data centre pipeline – the first capital raise in twelve years. The company has outlined a near-term pipeline of 0.5GW (of a total 5GW powerbank), with an end value of +$10bn (c.$20m/MW) and a GMG share of development cost of c.$2.7bn. Whilst the 1H25 result beat both Consensus and Morgans forecasts by c.10%-15%, forward guidance was reaffirmed (reflecting the earnings impact from the capital raise), with this slight downgrade drawing into question prior consensus expectations for further upgrades in FY25 and growth of c.12-13%. Whilst many unknowns remain, we (like many investors) believe in GMG’s capacity to take its industrial knowledge, institutional partnership and land/power bank to grow the data centre business. Valuation, however, remains a limiting factor hence our Hold rating and $38.00/sh target price. We would note that the target price reflects a 14.3% TSR on the issue price and as such encourage retail shareholders to participate in the SPP which closes c.13-Mar.

Strong across the board

MA Financial Group
3:27pm
February 20, 2025
MAF’s FY24 EBITDA (A$87m, +7% on the pcp) was broadly in-line with consensus ($86.5m), with the result also largely per Morgans expectations at NPAT. This was a strong result overall, in our view, with arguably the key highlight being a positive 2H24 EBITDA for MA Money, reflecting the company’s success in building out this new earnings stream. Our MAF FY25F/FY26F/FY27F EPS forecasts are altered by -2%/-4%/+5%, reflecting slightly more conservatism with near term margins, but also factoring in greater asset growth across the entire business medium term. Our PT is set A$8.92. We think MAF management are building a strong, differentiated franchise. We maintain our ADD recommendation, with ~10% upside to our target price

Better than expected, albeit costs skewed to 2H

Transurban Group
3:27pm
February 20, 2025
1H25 earnings and cashflow beat expectations, albeit were distorted by the skew of costs to 2H25. FY25 DPS guidance remained unchanged. TCL remains leveraged to population and economic growth trends in its regional markets. At current prices, TCL offers a c.4.9% cash yield with mid-single digit compound growth in DPS over coming years. However, long-term valuation is constrained by concession lives, interest rates, asset capacity, and debt retirement requirements. Hence, DCF-based 12 month target price set at $12.65. HOLD retained.

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more